Japan Autism Spectrum Disorder Treatment Market Size & Outlook, 2030

Revenue, 2022 (US$M)

$94.8

Forecast, 2030 (US$M)

$151.2

CAGR, 2023 - 2030

Report Coverage

Japan

Japan autism spectrum disorder treatment market, 2018-2030 (US$M)

Related Markets

Global Autism Spectrum Disorder Treatment Industry

North America Autism Spectrum Disorder Treatment Market Outlook

U.S. Autism Spectrum Disorder Treatment Market Outlook

Canada Autism Spectrum Disorder Treatment Market Outlook

Europe Autism Spectrum Disorder Treatment Market Outlook

Germany Autism Spectrum Disorder Treatment Market Outlook

France Autism Spectrum Disorder Treatment Market Outlook

Italy Autism Spectrum Disorder Treatment Market Outlook

Spain Autism Spectrum Disorder Treatment Market Outlook

Denmark Autism Spectrum Disorder Treatment Market Outlook

Sweden Autism Spectrum Disorder Treatment Market Outlook

Norway Autism Spectrum Disorder Treatment Market Outlook

UK Autism Spectrum Disorder Treatment Market Outlook

Asia Pacific Autism Spectrum Disorder Treatment Market Outlook

China Autism Spectrum Disorder Treatment Market Outlook

India Autism Spectrum Disorder Treatment Market Outlook

Australia Autism Spectrum Disorder Treatment Market Outlook

South Korea Autism Spectrum Disorder Treatment Market Outlook

Thailand Autism Spectrum Disorder Treatment Market Outlook

Latin America Autism Spectrum Disorder Treatment Market Outlook

Mexico Autism Spectrum Disorder Treatment Market Outlook

Argentina Autism Spectrum Disorder Treatment Market Outlook

Brazil Autism Spectrum Disorder Treatment Market Outlook

MEA Autism Spectrum Disorder Treatment Market Outlook

South Africa Autism Spectrum Disorder Treatment Market Outlook

Saudi Arabia Autism Spectrum Disorder Treatment Market Outlook

UAE Autism Spectrum Disorder Treatment Market Outlook

Kuwait Autism Spectrum Disorder Treatment Market Outlook

Japan autism spectrum disorder treatment market highlights

The Japan autism spectrum disorder treatment market generated a revenue of USD 94.8 million in 2022 and is expected to reach USD 151.2 million by 2030.
The Japan market is expected to grow at a CAGR of 6% from 2023 to 2030.
In terms of segment, stimulants was the largest revenue generating treatment type in 2022.
Antipsychotic Drugs is the most lucrative treatment type segment registering the fastest growth during the forecast period.

Autism spectrum disorder treatment market data book summary

Market revenue in 2022	USD 94.8 million
Market revenue in 2030	USD 151.2 million
Growth rate	6% (CAGR from 2022 to 2030)
Largest segment	Stimulants
Fastest growing segment	Antipsychotic Drugs
Historical data	2018 - 2021
Base year	2022
Forecast period	2023 - 2030
Quantitative units	Revenue in USD million
Market segmentation	Antipsychotic Drugs, Selective Serotonin Reuptake Inhibitors, Sleep Medications (Sedative & Hypnotic), Stimulants, Others Treatment
Key market players worldwide	Bristol-Myers Squibb Co, Merck & Co Inc, Novartis AG ADR, Eli Lilly and Co, Pfizer Inc, Johnson & Johnson, Otsuka Pharmaceutical, Roche Holding AG, Axial Biotherapeutics, Yamo Pharmaceuticals, Curemark

Other key industry trends

In terms of revenue, Japan accounted for 4.6% of the global autism spectrum disorder treatment market in 2022.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Asia Pacific, China autism spectrum disorder treatment market is projected to lead the regional market in terms of revenue in 2030.
China is the fastest growing regional market in Asia Pacific and is projected to reach USD 168.4 million by 2030.

Key Regions: U.S. , UK , Brazil , UAE , Canada

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

Autism Spectrum Disorder Treatment Market Scope

Autism spectrum disorder treatment market segmentation & scope

Autism Spectrum Disorder Treatment Market Companies

Name	Profile	# Employees	HQ	Website

Japan autism spectrum disorder treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to autism spectrum disorder treatment market will help companies and investors design strategic landscapes.

Stimulants was the largest segment with a revenue share of 26.69% in 2022. Horizon Databook has segmented the Japan autism spectrum disorder treatment market based on antipsychotic drugs, selective serotonin reuptake inhibitors, sleep medications (sedative & hypnotic), stimulants, others treatment covering the revenue growth of each sub-segment from 2018 to 2030.

Japan Autism Spectrum Disorder Treatment Treatment Type Outlook (Revenue, USD Million, 2018-2030)
- Antipsychotic Drugs
- Selective Serotonin Reuptake Inhibitors
- Sleep Medications (Sedative & Hypnotic)
- Stimulants
- Others Treatment
Japan Autism Spectrum Disorder Treatment Application Outlook (Revenue, USD Million, 2018-2030)
- Autistic Disorder
- Asperger Syndrome
- Pervasive Developmental Disorder
- Others Application
Japan Autism Spectrum Disorder Treatment Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy

Reasons to subscribe to Japan autism spectrum disorder treatment market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Japan autism spectrum disorder treatment market databook

Our clientele includes a mix of autism spectrum disorder treatment market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Japan autism spectrum disorder treatment market, including forecasts for subscribers. This country databook contains high-level insights into Japan autism spectrum disorder treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.